IT Tech Packaging Received Notice of Noncompliance

ING Group's 2026 SREP process shows unchanged Pillar 2 requirements, with CET1 and total capital requirements stable at 11.12% and 15.37%. Leverage ratio requirement remains 3.6%. ING's CET1 ratio and Leverage Ratio as of June 2026 are 13.1% and 4.2%, respectively, both above regulatory levels. ING shares are listed on Amsterdam, Brussels, and NYSE.

Wisconsin's attorney general has joined a lawsuit against Dollar General, alleging deceptive pricing practices. The state claims the retailer overcharged customers and failed to address the issue despite numerous complaints. The Federal Trade Commission has also noted years of similar complaints. Dollar General has not responded to the allegations.

Palvella Therapeutics (PVLA) received FDA Priority Review for QTORIN rapamycin gel to treat microcystic lymphatic malformations, with a decision expected by February 2027. The NDA is supported by positive Phase 3 trial results. PVLA stock rose 5.29% to $132.91 on Tuesday.

South Korea's KMCC fined Google and Apple 42.9B KRW and 20.81B KRW, respectively, for restricting app developers' payment options and charging high commissions. Both companies were ordered to revise their policies to allow more payment flexibility. Apple shares fell 0.37% in pre-market trading, while Google parent META shares rose 0.20%.

Russia's Roskomnadzor added Apple and Microsoft to a state surveillance registry on Oct. 2, requiring them to store user data and hand it over to security services. Non-compliance may result in penalties or service restrictions. Russia has tightened control over tech platforms since its 2022 invasion of Ukraine, according to Bloomberg.

electroCore (NASDAQ:ECOR) submitted a 510(k) application to the FDA for its Quell device to treat chemotherapy-induced peripheral neuropathy (CIPN). The submission is based on two studies showing pain score reductions and improvements in neuropathy symptoms. FDA clearance is not guaranteed, and Quell is not currently approved for CIPN.